No Data
Huaren Pharmaceutical (300110.SZ): Termination of the president position of Hong Liang.
On December 27, Glonghui reported that Huaren Pharmaceutical (300110.SZ) announced the convening of the sixth (extraordinary) meeting of the eighth Board of Directors on December 27, 2024, which reviewed and approved the "Proposal for the Dismissal of the Company's Chief Executive Officer." According to the needs of the company's Operation management, after the review by the Board of Directors' Nomination Committee, the Board of Directors agreed to dismiss Mr. Hong Liang from the position of Chief Executive Officer, with the dismissal taking effect from the date of approval by this Board of Directors meeting. Following the dismissal, Mr. Hong Liang will no longer hold any position within the company, and this dismissal will not adversely affect the normal operation of the company's daily production and Operation activities.
Huaren Pharmaceutical (300110.SZ): Currently, the company's export Business accounts for a small proportion.
On December 19, Gelonghui reported that Huaren Pharmaceutical (300110.SZ) stated on the investor interaction platform that, in terms of international business, the company's rubber stopper products have been exported to some countries in Europe and Asia. At the same time, the Pharmaceutical sector has successfully entered several pharmaceutical markets in Africa, Southeast Asia, and the Middle East. Currently, the company's export business occupies a relatively small proportion, and the company will actively expand its international business to fully explore new performance growth points.
Huaren Pharmaceutical Co., Ltd.'s (SZSE:300110) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?
Huaren Pharmaceutical (300110.SZ): Sodium bicarbonate Ringer's injection and sulfate terbutaline injection are proposed for selection in centralized procurement.
On December 13, Gelonghui reported that Huaren Pharmaceutical (300110.SZ) announced that the company and its wholly-owned subsidiary, Anhui Hengxing Pharmaceutical Co., Ltd., recently actively participated in the bidding for the tenth national centralized procurement organized by the National Organization for Pharmaceutical Joint Procurement Office. According to the results of the centralized procurement (Procurement Document No.: GY-YD2024-2) released by the procurement office, the company's product Sodium Bicarbonate Ringer's Injection and the product Sulfate Terbutaline Injection from its wholly-owned subsidiary Anhui Hengxing Pharmaceutical Co., Ltd. are proposed to be selected for this centralized procurement.
Huaren pharmaceutical (300110.SZ): Currently, the product field has not yet involved traditional chinese medicine business.
Huaren Pharmaceutical (300110.SZ) stated on the investor interaction platform on November 28 that the company is mainly engaged in the research and development, production, and sales of peritoneal dialysis solution, respiratory system medications, large volume infusions (including non-PVC flexible bags, upright flexible bags, plastic bottles, glass bottles for large infusions), analgesic medications, active pharmaceutical ingredients, supporting medical packaging materials, and medical instruments. The current product areas do not involve traditional Chinese medicine business.
Huaren Pharmaceutical (300110.SZ): The wholly-owned subsidiary has obtained the medical instruments registration certificate for disposable tracheal intubation.
On November 27, Geldhui announced that its wholly-owned subsidiary, Qingdao Huaren Medical Supplies Co., Ltd., recently received the "Medical Device Registration Certificate" for "Disposable Tracheal Tubes" issued by the Shandong Province Food and Drug Administration. The product models include HRQC-11, HRQC-12, HRQC-13, HRQC-14, HRQC-21, HRQC-22, HRQC-23, HRQC-24; with a total of 138 model specifications for establishing artificial airways during clinical anesthesia or emergencies.
Investors Give Huaren Pharmaceutical Co., Ltd. (SZSE:300110) Shares A 30% Hiding
